Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study

• Asıl Yazarlar: O.M. Moreno-Arrones (Yazar), S. Béa-Ardebol (Yazar), F. Mayo-Martinez (Yazar), G. Pérez-Pastor (Yazar), I. Torres-Navarro (Yazar), M. Bonfill-Ortí (Yazar), G. Deza (Yazar), V. Ruiz-Salas (Yazar), E. Masferrer (Yazar), C. Feal (Yazar), L. Turrión-Merino (Yazar), A. Toll (Yazar), M. Yébenes (Yazar), S. Galiano-Mejías (Yazar), A. Jaka (Yazar), C. Ferrandiz-Pulido (Yazar), A. Florez (Yazar), N. Hernández-Hernández (Yazar), R. Fernández- (Yazar), L. Rios-Buceta (Yazar), O. Sanmartin (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2023-07-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: Basal cell carcinoma (BCC) is the most prevalent cancer. A minority of BCCs have an aggressive behaviour (laBCC) and may require hedgehog pathway inhibitors such as sonidegib as its treatment. Objective: To describe the use of sonidegib in a large number of patients and provide more data...